Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells.

Abstract

Unrelated cord blood transplantation (CBT) without in vivo T-cell depletion is increasingly used to treat high-risk hematologic malignancies. Following T-replete CBT, naïve CB T cells undergo rapid peripheral expansion with memory-effector differentiation. Emerging data suggest that unrelated CBT, particularly in the context of HLA mismatch and a T-replete graft, may reduce leukemic relapse. To study the role of CB T cells in mediating graft-versus-tumor responses and dissect the underlying immune mechanisms for this, we compared the ability of HLA-mismatched CB and adult peripheral blood (PB) T cells to eliminate Epstein-Barr virus (EBV)-driven human B-cell lymphoma in a xenogeneic NOD/SCID/IL2rg(null) mouse model. CB T cells mediated enhanced tumor rejection compared with equal numbers of PB T cells, leading to improved survival in the CB group (P < .0003). Comparison of CB T cells that were autologous vs allogeneic to the lymphoma demonstrated that this antitumor effect was mediated by alloreactive rather than EBV-specific T cells. Analysis of tumor-infiltrating lymphocytes demonstrated that CB T cells mediated this enhanced antitumor effect by rapid infiltration of the tumor with CCR7(+)CD8(+) T cells and prompt induction of cytotoxic CD8(+) and CD4(+) T-helper (Th1) T cells in the tumor microenvironment. In contrast, in the PB group, this antilymphoma effect is impaired because of delayed tumoral infiltration of PB T cells and a relative bias toward suppressive Th2 and T-regulatory cells. Our data suggest that, despite being naturally programmed toward tolerance, reconstituting T cells after unrelated T-replete CBT may provide superior Tc1-Th1 antitumor effects against high-risk hematologic malignancies.

DOI: 10.1182/blood-2015-06-654780

7 Figures and Tables

0200400600201520162017
Citations per Year

355 Citations

Semantic Scholar estimates that this publication has 355 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Hiwarkar2015CordBT, title={Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells.}, author={Prashant Hiwarkar and Waseem Qasim and Ida Ricciardelli and Kimberly C Gilmour and Sergio A. Quezada and Aurore Saudemont and Persis Jal Amrolia and Paul A. Veys}, journal={Blood}, year={2015}, volume={126 26}, pages={2882-91} }